RESOURCE CENTER

The Resource Center operates in the fast-moving cell and gene therapy space, providing critical resources that brokers and employers depend on to stay informed. But their resource center — the core of their value to clients — was running on a third-party platform that wasn't designed for their needs.

The pain points were clear:

• Generic user experience with no way to distinguish between broker and employer audiences
• No custom branding — the platform didn't reflect their expertise or credibility
• Recurring subscription fees for software they didn't own and couldn't shape
• Locked into a vendor's roadmap with no ability to customize

They had no alternatives. Traditional custom development felt too expensive and too slow to be realistic. So they were stuck — paying for a tool that didn't serve their audience properly, in a space where credibility and trust are everything.

The team was skeptical about AI-assisted development, but they trusted the people behind OneChair.dev enough to take a leap. That trust was rewarded quickly.

The Speed: Using AI-orchestrated development, OneChair delivered the first working iteration in just 1.5 weeks. The full platform launched in under a month.

The Iteration Advantage: When feedback came in or changes were needed, they were reflected in the product almost immediately — a pace that would be impossible with traditional development. The team wasn't reviewing a spec doc and hoping for the best. They were shaping a live product in real time.

What Was Built:

• Completely redesigned user experience purpose-built for the cell and gene therapy audience
• Support for multiple user types with tailored experiences for brokers and employers
• Custom branding fully integrated into the platform ecosystem
• Complete platform ownership — no more recurring fees or vendor dependence

Immediate ROI:

• One-time investment pays for itself in approximately 8 months of eliminated subscription costs
• After break-even, ongoing savings compound year over year
• Platform has potential to become a revenue-generating asset through premium content and expanded services

Strategic Value:

• Full control over the platform roadmap — no waiting on a vendor for feature requests
• Ability to evolve the resource center as the cell and gene therapy landscape changes
• Custom features and adjustments can be made without third-party approval or additional fees

What Comes Next: The team is already planning a significantly larger engagement — a full case management platform — with OneChair. Coming back for a bigger, more complex project is the strongest possible endorsement of the first one.

• For companies stuck on legacy platforms: "Too expensive and too slow" is no longer a valid reason to stay with a platform that doesn't serve your audience. AI-orchestrated development makes custom builds viable for the first time.
• For industries where credibility matters: A subpar digital experience undermines your position as an expert. Owning your platform means your digital presence matches your domain authority.
• For long-term ROI: Recurring subscription costs add up. A one-time investment that pays for itself in 8 months and then generates pure savings is a fundamentally better financial model.